Definitive Contract 00266200309D266030047

Ended Awarded Last action

Contract number
00266200309D266030047
Awardee
Awarding agency
Obligated
$10,998,697

Award facts

Contract value 41% obligated
  • $10,642,635.00 Current, with exercised options
  • $26,986,655.00 Potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 16 offers
Pricing
Cost Plus Fixed Fee
Place of performance
Birmingham, AL 35255, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 13 $967,812
Funding Only Action 12 $967,812
Other Administrative Action 11 · 30047 change key personnel $0
Funding Only Action 10 · 30047 incremental funding can 8470036 $1,866,151
Other Administrative Action 9 $0
Funding Only Action 8 $1,205,477
Funding Only Action 7 $1,734,731
Other Administrative Action 6 $0
Other Administrative Action 5 $0
Other Administrative Action 4 · In vitro antiviral screening program - hepatitis C & B virus $0
Funding Only Action 3 $1,672,568
Other Administrative Action 2 $0
Funding Only Action 1 · In vitro antiviral screening program - hepatitis C & B virus $1,294,222
Original award $1,289,924
Show all 14

About this award

Written by GovTribe AI ·

This is a federal contract award to Southern Research Institute, a non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID) under the Department of Health and Human Services (HHS). The contract has a ceiling value of $26,986,655.00 and was awarded on September 15, 2003 with a period of performance through September 29, 2010. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type.

Southern Research Institute, also known as Southern Research, is a provider of advanced technologies and contract research services, including drug discovery and development, emerging infectious disease research, medicinal chemistry, and toxicology. This contract award is not set aside and is likely part of NIAID's broader efforts to support research and development in areas such as HIV therapeutics, antimicrobials, and antiviral treatments. Southern Research has a history of providing services to various federal agencies, including the CDC, Department of Energy, Department of Defense, and EPA, through both prime and sub-contract awards.

Quick answers

Who was awarded contract 00266200309D266030047?

00266200309D266030047 was awarded to Southern Research Institute by NIAID DEA OA Acquisitions (National Institutes of Health) on September 15, 2003.

How much is contract 00266200309D266030047 worth?

The government has obligated $10,998,697 on 00266200309D266030047. Its current value, with exercised options, is $10,642,635. Its potential value, with all options, is $26,986,655.

Was contract 00266200309D266030047 competed?

The extent of competition for 00266200309D266030047 was full and open competition. The government received 16 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login